| 中文名称 | 甲磺酸伊马替尼 |
|---|---|
| 中文别名 | 甲磺酸伊马替尼;4-[(4-甲基-1-哌嗪基)甲基]-N-[4-甲基-3-[4-(3-吡啶基)-2-嘧啶基]氨基]苯基]苯甲酰胺甲磺酸盐;4-[(4-甲基-1-哌嗪基)甲基]-N-[4-甲基-3-[4-(3-吡啶基)-2-嘧啶基]氨基]-苯基]苯甲酰胺甲磺酸盐;依马替尼;格列维克;甲磺酸依马替尼;伊马替尼甲磺酸盐;2-(4-甲氧基苯氧基)丙酸;格列卫;甲磺酸阿帕替尼;甲磺酸伊马替尼(A和B);甲磺酸伊马替尼(格列卫);甲硫酸伊马替尼;伊马替尼;左旋舒必利;IMA锡IB甲磺酸盐;甲磺酸伊玛替尼;格列维克原材料;甲磺酸伊马替尼(抗肿瘤);甲磺酸伊马替尼(对照品);伊马替尼系统适用性 |
| 英文名称 | Imatinib mesylate |
| 英文别名 | Imatinib Mesylate;4-[(4-methyl-1-piperazinyl)methyl]-n-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide monomethanesulfonate;4-[(4-methylpiperazin-1-yl)methyl]-n-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide methanesulfonate;CGP-57148B;GLEEVEC;GLIVEC;IMATINIB METHANESULFONATE;STI-571;IMATINIB BASE(IMA-3);Imatinib Methanesulfonate, STI-571, CGP-57148B, Glivec;IMATINIB MESYLATE (IMATINIB METHANESULFONATE);alpha-IMATINIB MESYLATE;Imatinib mesylate(TINIBS );Imatinib Mesylate (STI571);4-(4-Methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)phenyl]benzamide methanesulfonic aci...;4-(4-Methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)phenyl]benzamide methanesulfonic acid salt;Gleevec (Imatinib Mesylate);Imatinib;Imatinib (mesylate);Imatinib Mesilate;Imatinib Mesylate (Imatinib Methanesulfonate,Gleevec®,Glivec® );Imatinnib Mesylate;matinib mesylate;Gleevac;Imantinib mesylate;Imatinib mesylate;4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide methanesulfonate;4-[(4-Methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide mesylate;CGP 57148;Genfatinib;imatinib monomesylate;CGP 57148B;Imatinib, methanesulfonate salt;8A1O1M485B;STI 571;Imatinib mesylate, 98%;Imatinib mesylate (USAN);Imatinib mes;Imatinib mesylate [USAN];DSSTox_RID_79501;DSSTox_CID_20502;DS;STI571 Mesylate;CGP-57148B Mesylate;Imatinib mesylate?;Q-201232;220127-57-1;4-[(4-methyl-1-piperazinyl)methyl]-n-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide methanesulfonate;;4-[(4-Methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide methanesulfonate;CHEMBL1642;HMS3394B09;MFCD04307699;QTI571;BCPP000204;HMS3372O12;I0936;Imatinib medac;IMATINIB MESYLATE [VANDF];Glivec (TN);IMATINIB MESILATE (EP MONOGRAPH);BENZAMIDE, 4-((4-METHYL-1-PIPERAZINYL)METHYL)-N-(4-METHYL-3-((4-(3-PYRIDINYL)-2-PYRIMIDINYL)AMINOPHENYL)-, METHANESULFONATE SALT;HMS3265E01;EX-A954;J-523068;Imatinib monomethanesulfonate;Imatinib methane sulfonate;D01441;220127-57-1 (mesylate);SCHEMBL8217;4-[(4-Methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]benzamide methanesulfonate;MLS001401456;IMATINIB MESILATE [WHO-DD];HMS2233D16;GGP-57148B;QTI-571;N-(4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide methanesulfonate;AKOS015852497;HSDB 7142;HMS3265E02;NCGC00159456-02;Imatinib mesylate400 mg;AM20080900;Imatinib (as mesilate);NSC 716051;IMATINIB MESYLATE [HSDB];CCG-101175;A846640;HMS3265F01;C29H31N7O.CH4O3S;4-((4-Methyl-1-piperazinyl)methyl)-N-(4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)phenyl)benzamide Monomethanesulfonate;Gleevec (TN);CGP-57148;HMS3265F02;NCGC00159456-11;CAS-220127-57-... |
| CAS No. | 220127-57-1 |
| 分子式 | C30H35N7O4S |
| 分子量 | 589.71 |
4-(2-((2R,3R)-3-(2,5-二氟苯基)-3-羟基-4-(1H-1,2,4-三唑-1-基)丁-2-基)噻唑-4-基)苯甲腈
N-(丁基磺酰基)-O-[4-(4-哌啶基)丁基]-L-酪氨酸盐酸盐一水合物
2-(4-(1-羟基-4-(4-(羟基二苯基甲基)哌啶-1-基)丁基)苯基)-2-甲基丙酸
7-环戊基-N,N-二甲基-2-((5-(哌嗪-1-基)吡啶-2-基)氨基)-7H-吡咯并[2,3-d]嘧啶-6-甲酰胺
(1-((2R,3R,4S,5R)-3,4-二羟基-5-甲基四氢呋喃-2-基)-5-氟-2-氧代-1,2-二氢嘧啶-4-基)氨基甲酸戊酯
((3S,5R)-5-((1H-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氢呋喃-3-基)甲基 4-甲基苯磺酸酯
N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉-4-丙氧基)喹唑啉-4-胺
(6R,7R)-3-甲基-7-[(R)-2-氨基-2-苯乙酰氨基]-8-氧-5-硫杂-1-双环[4.2.0]辛-2-烯-2-甲酸
(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇
(2R,3R,4S,5R)-2-(4-氨基吡咯并[2,1-F][1,2,4]三嗪-7-基)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-甲腈
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。
CopyRight @2025 广东元丰化学试剂有限公司 版权所有 | 隐私政策 条款及条件 | 粤ICP备2025403430号-1
技术支持:库价化学